5 Specifications That The FDA’s Diversity Plan Needs To Include

It is an exciting place to be when we can objectively look at history in a way, we can action meaningful changes today and into the future. I was privileged to recently write an article for Clinical Leader Magazine. I invite you to read this article with an open mind and warm heart as I highlight five specifications in the FDA’s diversity plan that I feel require emphasis. I welcome your support as together WE ARE THE CHANGE.

5 Specifications That The FDA's Diversity Plan Needs To Include

By Maimah Karmo, CEO and president, Tigerlily Foundation